[Is it possible to prevent mycotic infections in oncology patients?].
The authors give an account on prophylactic provisions focused on reduction of the risk of mycotic infections in oncological patients. After a brief introduction where they point out the importance of mycotic infections they pay their main attention to the prophylactic administration of drugs. They deal with procedures used and in the majority they quote original sources. Main emphasis is laid on the probably most perspective preparation-fluconazol. The authors present also their own views.
II. interní klinika FN Brno-Bohunice.
J
J
Mayer
J
J
Vorlícek
D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D009181:Mycoses / Q000150:complications / Q000517:prevention & control*; D009369:Neoplasms / Q000150:complications*; D009894:Opportunistic Infections / Q000150:complications / Q000517:prevention & control*
D000935:Antifungal Agents
Lze zabránit vzniku mykotických infekcí u onkologických pacientů?